Sanctuary Advisors LLC Takes Position in Danaher Corporation $DHR

Sanctuary Advisors LLC purchased a new position in Danaher Corporation (NYSE:DHR) in the second quarter, Holdings Channel reports. The fund purchased 51,553 shares of the conglomerate’s stock, valued at approximately $9,820,000.

Several other institutional investors have also made changes to their positions in the stock. BlackRock Inc. purchased a new position in Danaher in the second quarter valued at about $10,492,520,000. State Street Corp raised its stake in shares of Danaher by 1.7% during the 4th quarter. State Street Corp now owns 27,681,334 shares of the conglomerate’s stock worth $6,345,529,000 after purchasing an additional 472,608 shares in the last quarter. Capital International Investors raised its stake in shares of Danaher by 8.9% during the 4th quarter. Capital International Investors now owns 18,246,008 shares of the conglomerate’s stock worth $4,177,386,000 after purchasing an additional 1,487,768 shares in the last quarter. Price T Rowe Associates Inc. MD lifted its holdings in shares of Danaher by 9.1% during the 4th quarter. Price T Rowe Associates Inc. MD now owns 15,973,240 shares of the conglomerate’s stock valued at $3,656,595,000 after buying an additional 1,334,221 shares during the last quarter. Finally, Wellington Management Group LLP lifted its holdings in shares of Danaher by 11.2% during the 4th quarter. Wellington Management Group LLP now owns 15,076,796 shares of the conglomerate’s stock valued at $3,451,380,000 after buying an additional 1,517,904 shares during the last quarter. 79.05% of the stock is currently owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

A number of research firms recently commented on DHR. HSBC dropped their price objective on Danaher from $270.00 to $230.00 and set a “buy” rating on the stock in a report on Wednesday, June 3rd. Wolfe Research cut shares of Danaher from an “outperform” rating to a “peer perform” rating in a research note on Monday, June 1st. Citigroup began coverage on shares of Danaher in a research report on Tuesday, May 26th. They issued a “buy” rating and a $230.00 target price for the company. Evercore restated an “outperform” rating and set a $230.00 price target on shares of Danaher in a research note on Monday, July 6th. Finally, Stifel Nicolaus cut their price target on shares of Danaher from $260.00 to $220.00 and set a “buy” rating on the stock in a report on Wednesday, July 22nd. One equities research analyst has rated the stock with a Strong Buy rating, nineteen have assigned a Buy rating and five have assigned a Hold rating to the company’s stock. According to data from MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and a consensus target price of $228.91.

Danaher Trading Down 1.7%

Shares of DHR stock opened at $215.18 on Tuesday. The firm has a market capitalization of $151.27 billion, a P/E ratio of 38.22, a price-to-earnings-growth ratio of 2.72 and a beta of 0.78. Danaher Corporation has a 1 year low of $160.93 and a 1 year high of $242.80. The firm’s fifty day simple moving average is $196.49 and its 200 day simple moving average is $192.39. The company has a current ratio of 1.65, a quick ratio of 1.25 and a debt-to-equity ratio of 0.48.

Danaher (NYSE:DHR) last issued its quarterly earnings results on Monday, July 20th. The conglomerate reported $1.94 earnings per share for the quarter, beating analysts’ consensus estimates of $1.85 by $0.09. The firm had revenue of $6.26 billion during the quarter, compared to the consensus estimate of $6.12 billion. Danaher had a net margin of 15.95% and a return on equity of 11.04%. The business’s revenue was up 5.5% on a year-over-year basis. During the same period in the prior year, the firm earned $0.77 EPS. As a group, sell-side analysts predict that Danaher Corporation will post 8.53 EPS for the current year.

Danaher Company Profile

Danaher Corporation (NYSE: DHR) is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.

Products and services in Danaher’s portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.